Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Neuro-Oncology|January 14, 2017
Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosisAna Xavier-Magalhães, Ana I Oliveira, Joana Vieira de Castro, et al.
Theranostics|October 4, 2018
WNT6 is a novel oncogenic prognostic biomarker in human glioblastomaCéline S Gonçalves, Joana Vieira de Castro, Marta Pojo, et al.
Cancer Immunology Research|November 24, 2021
Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in CancerWard Celus, Ana I Oliveira, Silvia Rivis, et al.
Neuro-Oncology|September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcomaNicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Oncotarget|April 13, 2018
The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant gliomaAna Xavier-Magalhães, Céline S Gonçalves, Anne Fogli, et al.
Cancer Cell|September 12, 2018
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent MannerAndrew Mancini, Ana Xavier-Magalhães, Wendy S Woods, et al.
Oncology Reports|April 30, 2010
Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre studyBruno M Costa, Cláudia Caeiro, Inês Guimarães, et al.
Pageof 6